Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Post by jolanta12on Mar 11, 2020 1:48pm

72 Views

Post# 30794316

Soon we will be talking real $$$$ not cents !!!!

Forget this Sh.....### t cents !!!! This is company that was working so hard with their reseach that
you are witnessing transforming to bigh $$$$$ company !!!!!

F....uk of dirty shorters and penny fliippers son . WE are going to the Premiere Ligue!!!!!!

It is still cheap as dirt !!!!

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?